全球医学影像市场 - 2023-2030
市场调查报告书
商品编码
1345423

全球医学影像市场 - 2023-2030

Global Medical Imaging Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球医学影像市场在 2022 年达到 402 亿美元,预计到 2030 年将达到 593 亿美元,2023-2030 年预测期间复合年增长率为 5.1%。

医学成像涉及对身体内部进行成像以进行临床分析和医疗干预的过程,以及某些器官或组织功能的视觉表示。每种类型的成像技术都会提供有关正在研究或治疗的身体区域的不同信息,这些信息与可能的疾病、损伤或医疗治疗的有效性相关。

医学成像技术带来了临床解剖学和法医病理学的巨大进步。新兴技术使医疗保健专业人员能够从不同的角度观察和理解人体。常用的医学成像设备包括X射线、计算机断层扫描(CT)、正电子发射断层扫描(PET)、超声波和磁共振成像(MRI)。

此外,政府和私人组织投资增加、产品发布以及研发不断增加等重要增长动力将推动未来市场的增长。 Koninklijke Philips NV、GE Healthcare、Shimadzu Corporation、Toshiba Medical Systems Inc. 等重要参与者都在市场上积极运营。

动力学

增加医疗成像设备的产品推出预计将推动市场增长

医学成像设备广泛用于诊断肌肉骨骼疾病、心脏病、癌症和慢性肺部疾病等慢性疾病。大公司的重大技术进步有助于推动市场增长。这些有效的产品发布有助于将研究发现转化为新的治疗方法,并改善对数百万慢性病患者的护理。

例如,2023 年 7 月,柯尼卡美能达医疗保健美洲公司推出了 PocketPro H2,这是一款新型无线手持式超声设备,用于护理点应用中的一般成像。 PocketPro H2 线性无线手持式超声系统针对肌肉骨骼 (MSK)、疼痛管理、血管通路和针引导应用进行了优化。具有出色的图像质量。

此外,飞利浦于 2023 年 5 月推出了飞利浦图像引导治疗移动 C 形臂系统 1000,名为 Zenition 10。飞利浦 Zenition 10 旨在通过提供速度和效率来解决高患者吞吐量问题。它还可以灵活地满足创伤、骨科和其他手术领域的要求。因此,上述因素有助于提振市场。

政府和私人组织的投资刺激了其在全球市场的需求

政府在全球医疗设备的采购、定价和分销方面发挥着重要作用。各国政府采取各种倡议来发展医疗保健基础设施,以便为公众提供安全且具有成本效益的医疗产品。政府机构的资助也有助于开设新设施。此外,实施符合进出口的法规预计将有助于为市场创造收入。

例如,2023 年 5 月,英国政府拨款 23 亿英镑建设 160 个新的社区诊断中心,以减轻 NHS 的压力并改善患者护理。预计每年可提供超过 500,000 次额外检查、成像和扫描。

此外,2023 年 3 月,加拿大全球医疗技术创新公司 Synaptive Medical Inc. 获得加拿大出口发展局 (EDC) 4000 万美元的投资,用于加速手术、成像和数据技术的发展。这笔 4000 万美元的投资用于开发和扩大对加拿大製造的手术机器人、MRI 以及医学成像和手术室数据平台的使用。

医疗成像设备的产品召回将阻碍全球医疗成像设备市场的增长

过去几年,全球医学成像市场发生了重大产品召回事件。当产品缺陷可能影响或伤害消费者、损害公司声誉并阻碍市场增长时,就会发生产品召回。越来越多的此类事件导致不准确的错误,并且在医学成像市场上出现了一些重大的产品召回事件。

例如,2022 年 5 月 26 日,雅培医疗在美国召回了 4,800 个 Dragonfly OpStar 成像导管。此外,2023 年 2 月,GE HealthCare 召回了一些可能导致严重伤害或死亡的核医学成像系统。它属于 GE 的核医学 600 和 800 系列系统,用于检测和诊断癌症和神经系统疾病。

目录

第 1 章:方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义和概述

第 3 章:执行摘要

  • 按产品分类的片段
  • 按应用程序片段
  • 最终用户摘录
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 增加医疗影像设备的产品发布
      • 政府和私人组织的投资
    • 限制
      • 医疗成像设备产品召回
    • 机会
    • 影响分析

第 5 章:行业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情况
    • COVID-19 后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商的战略倡议
  • 结论

第 7 章:副产品

  • X射线
  • CT检查
  • 正电子发射断层扫描 (PET)
  • 超声波系统
  • 核磁共振设备
  • 核成像
  • 触觉成像
  • 光声成像
  • 热成像
  • 弹性成像
  • 超声心动图

第 8 章:按应用

  • 心脏病学
  • 骨科
  • 胃肠病学
  • 妇科
  • 肿瘤学
  • 神经病学
  • 其他的

第 9 章:最终用户

  • 诊断中心
  • 医院
  • 专科诊所
  • 其他的

第 10 章:按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 产品基准化分析
  • 公司股份分析
  • 主要进展和策略

第 12 章:公司简介

  • Koninklijke Philips NV
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • GE Healthcare
  • Shimadzu Corporation
  • Toshiba Medical Systems Inc.
  • Ziehm Imaging Inc.
  • Varian Medical Systems
  • Aribex Corporation
  • Fujifilm Holdings Corporation
  • Siemens Healthcare
  • Hitachi Ltd.

第 13 章:附录

简介目录
Product Code: MI213

Overview

Global Medical Imaging Market reached US$ 40.2 billion in 2022 and is expected to reach US$ 59.3 billion by 2030 growing with a CAGR of 5.1% during the forecast period 2023-2030.

Medical imaging involves the process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. Each type of imaging technology gives different information about the area of the body being studied or treated which is related to possible disease, injury, or the effectiveness of medical treatment.

Medical imaging techniques have led to great advances in clinical anatomy and forensic pathology. New and emerging technologies allow healthcare professionals to view and understand the human body from different perspectives. Commonly used medical imaging equipment includes X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound, and magnetic resonance imaging (MRI).

Furthermore, significant growth drivers such as the increasing investments by government and private organizations, product launches, and rising research and developments give rise to future market growth. Significant key players like Koninklijke Philips N.V., GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., and others are actively operating in the market.

Dynamics

Increasing Product Launches of Medical Imaging Equipment is Expected to Boost Market Growth

Medical imaging devices are widely used in diagnosing chronic conditions like musculoskeletal disorders, cardiac disease, cancers, and chronic lung diseases. The major technological advancements by major companies help to drive market growth. These effective product launches help to transform research discoveries into new treatments and improve care for millions of people with chronic diseases.

For instance, in July 2023, Konica Minolta Healthcare Americas, Inc., launched PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications. The PocketPro H2 linear wireless handheld ultrasound system is optimized for musculoskeletal (MSK), pain management, vascular access, and needle guidance applications. with excellent image quality.

Additionally, in May 2023, Philips launched the Philips Image Guided Therapy Mobile C-arm System 1000, named Zenition 10. Philips Zenition 10 is designed to address high patient throughput by providing speed and efficiency. It also provides the flexibility to accommodate the requirements of trauma, orthopedics, and other areas of surgery. Thus, the above factors help to boost the market.

Investments by Government and Private Organizations Fuel its Demand in the Global Market

Government plays an important role in purchasing, pricing, and distributing medical devices globally. Governments undertake various initiatives to develop healthcare infrastructure to provide safe and cost-effective medical products to the public. The funding by government bodies also helps in opening new facilities. Also, implementing regulations that comply with imports and exports is expected to help generate revenue for the market.

For instance, in May 2023, the United Kingdom Government funded £2.3 billion into 160 new community diagnostic centers to reduce pressure on the NHS and improve patient care. It is expected to provide over 500,000 additional checkups, imaging, and scans a year.

Additionally, in March 2023, Synaptive Medical Inc., a global medical technology innovator in Canada, secured a USD $40 million investment from Export Development Canada (EDC) to accelerate surgical, imaging, and data technologies. The $40 million investment is to develop and expand access to Canadian-made surgical robotics, MRI, and data platforms for medical imaging and operating rooms.

Product Recalls Of Medical Imaging Equipment Will Hamper The Global Medical Imaging Equipment Market Growth

The global medical imaging market has witnessed major product recalls in the past few years. Product recalls occur when a product defect could affect or harm the consumer, hampers a company's reputation, and hinders market growth. An increasing number of such instances result in inaccuracy errors and some major instances of product recall witnessed in the medical imaging market.

For instance, on 26 May 2022, Abbott Medical Recalled 4,800 Dragonfly OpStar Imaging Catheters in the U.S. Additionally, in February 2023, GE HealthCare recalled some of its nuclear medicine imaging systems that could cause serious injury or death. It pertains to GE's Nuclear Medicine 600 and 800 Series systems, used for detecting and diagnosing cancer, and neurological disorders.

Segment Analysis

The global medical imaging market is segmented based on product, application, end users, and region.

X-rays from the Product Segment Accounted for Approximately 37.5% of the Global Medical Imaging Market Share

The X-ray segment has the most significant share of the medical imaging equipment market due to the system's versatility and convenience. An X-ray is a noninvasive medical imaging test that helps physicians diagnose and treat medical conditions. X-rays diagnose skeletal systems, oral cavities, lungs, breast, digestive systems, and ingested objects. The growth in the X-ray segment is mainly due to its cost-effectiveness

For instance, in July 2022, Shimadzu Corporation introduced a New Type of Mobile X-ray System Outside of Japan, accommodating a Wide Range of Needs for Mobile X-ray Systems. This system incorporates digital radiography (DR) and this Mobile X-ray system provides diagnostic imaging and can travel to patient rooms, operating rooms, and emergency areas.

For instance, on August 02, 2022, GE Healthcare launched its most advanced fixed X-ray system called the next-generation Definium 656 HD. The Definium 656 HD, featuring the Intelligent Workflow Suite, is a versatile and digital radiographic system powered by GE's FlashPad HD high-resolution detectors and the latest Helix 2.2 advanced image processing software.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America has maintained a significant proportion of the medical imaging market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as rising product launches, healthcare expenditure, and research and developments in medical imaging equipment.

For instance, in August 2023, GE HealthCare launched the handheld ultrasound device Vscan Air SL. The dual-headed probe of Vscan Air SL enables clinicians to access sector and linear arrays on the same device that is capable of facilitating rapid vascular and cardiac assessments of patients.

Competitive Landscape

The major global players in the market include: Koninklijke Philips N.V, GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., Ziehm Imaging Inc., Varian Medical Sytems, Aribex Corporation, Fujifilm Holdings Corporation, Siemens Healthcare, Hitachi Ltd. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical imaging market. During the height of the pandemic, many healthcare systems were overwhelmed, and non-urgent medical procedures and screenings were postponed or canceled. This led to delays in medical imaging device research and product launches. Clinical trials are vital for developing new treatments and improving outcomes in the medical imaging market.

However, the pandemic disrupted the conduct of clinical trials, with many sites temporarily halting enrollment or modifying protocols to prioritize patient safety. This has led to delays in the completion of trials and the availability of new therapies. Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical imaging market is expected to be moderately affected over the forecast period.

By Product

  • X-Ray
  • Computed Tomography
  • Positron Emission Tomography (PET)
  • Ultrasound System
  • MRI Equipment
  • Nuclear Imaging
  • Tactile Imaging
  • Photoacoustic Imaging
  • Thermography
  • Elastography
  • Echocardiography

By Application

  • Cardiology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Oncology
  • Neurology
  • Others

By End Users

  • Diagnostic Centers
  • ASCs
  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May 2023, Claritas HealthTech entered into a collaboration with PwC for the deployment of its medical imaging platforms. This collaboration helps the companies work together to roll out, install, and support medical image enhancement and artificial intelligence (AI) diagnostic software products suite.
  • In February 2023, Mindray launched the handheld ultrasound system TE Air. TE Air offers crisp, high-quality ultrasound images, and facilitates radiology workflow with seamless integration into hospital information systems and can be connected with other systems.
  • In September 2022, Philips Foundation and RAD-AID International embarked on a multi-year cross-continental partnership to increase access to ultrasound services for 50 million people in low- and middle-income countries.

Why Purchase the Report?

  • To visualize the global medical imaging market segmentation based on product, application, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global medical imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical imaging market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing product launches of medical imaging equipment
      • 4.1.1.2. Investments by government and private organizations
    • 4.1.2. Restraints
      • 4.1.2.1. Product recalls of medical imaging equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. X-Ray
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Computed Tomography
  • 7.4. Positron Emission Tomography (PET)
  • 7.5. Ultrasound System
  • 7.6. MRI Equipment
  • 7.7. Nuclear Imaging
  • 7.8. Tactile Imaging
  • 7.9. Photoacoustic Imaging
  • 7.10. Thermography
  • 7.11. Elastography
  • 7.12. Echocardiography

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedics
  • 8.4. Gastroenterology
  • 8.5. Gynecology
  • 8.6. Oncology
  • 8.7. Neurology
  • 8.8. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Diagnostic Centers
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Koninklijke Philips N.V*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. GE Healthcare
  • 12.3. Shimadzu Corporation
  • 12.4. Toshiba Medical Systems Inc.
  • 12.5. Ziehm Imaging Inc.
  • 12.6. Varian Medical Systems
  • 12.7. Aribex Corporation
  • 12.8. Fujifilm Holdings Corporation
  • 12.9. Siemens Healthcare
  • 12.10. Hitachi Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us